High-yield reporting fields for suspected semaglutide-related vaginal symptoms include: dose and escalation dates, concomitant SGLT2 inhibitor use, antibiotic/antifungal use, menopausal status/HRT, diabetes control markers, symptom description with onset/offset, objective test results (pH, microscopy/NAAT), and dechallenge/rechallenge outcomes if they occur
Wroblewski LE, Peek RM Jr., Wilson KT
glucagon receptor activation stimulates -oxidation of fatty acids, reducing hepatic lipid content, while GLP-1 enhances systemic insulin sensitivity and decreases lipolysis in adipose tissue, thereby indirectly reducing hepatic fat influx ( 3.3.3 Anti-inflammatory and anti-fibrotic effects The anti-inflammatory and anti-fibrotic potential of GLP-1 receptor activation has garnered significant attention in the context of liver disease
A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls
If you have not achieved sufficient or sustained results with these efforts, Zepbound may be an option as part of your personalized care plan